A Randomized Double Blind Trial Comparing Reversal With Low Doses Of Sugammadex aFter Rocuronium-induced Neuromuscular Block Under General Anesthesia in Patients Undergoing Non-cardiac Surgery(TOF TRIAL)
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 Jun 2018
At a glance
- Drugs Sugammadex (Primary) ; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- Acronyms TOF
- 27 May 2018 Planned number of patients changed from 475 to 144.
- 27 May 2018 Planned initiation date changed from 1 Apr 2018 to 1 Aug 2018.
- 20 Nov 2017 New trial record